ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.

Li-Kai Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.